# P4.07D.04 Trofuse-019: A Phase 3 Study of Adjuvant Pembrolizumab with or without Sac-TMTfor Resectable Stage II-IIIB (N2) NSCLC

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/p4-07d-04-trofuse-019-a-phase-3-study-of-adjuvant-pembrolizumab-with-or-without/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jang‐Ming Lee,B.-C. Liao,Jonathan Spicer,T. Newsom-Davis,RosalineChung-Yee Hui,Yiquan Xu,A. Song,Ayman Samkari,M. Hochmair |
| Citations | 4 |
| DOI | 10.1016/j.jtho.2024.09.682 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4403419825 |
| Type | article |
| Year | 2024 |

## Paper authors

- [B.-C. Liao](https://scholariq.org/researchers/b-c-liao/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.